B60002
[(1R)-(内型，反式)]-(+)-3-溴樟脑-8-磺酸 铵盐
99%
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C10H15BrO4S · NH3
化学文摘社编号:
分子量:
328.22
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352115
EC Number:
238-616-9
MDL number:
Assay:
99%
Form:
powder
产品名称
[(1R)-(内型，反式)]-(+)-3-溴樟脑-8-磺酸 铵盐, 99%
InChI
1S/C10H15BrO4S.H3N/c1-9-4-3-6(7(11)8(9)12)10(9,2)5-16(13,14)15;/h6-7H,3-5H2,1-2H3,(H,13,14,15);1H3/t6-,7+,9+,10-;/m1./s1
InChI key
GFBVBBRNPGPROZ-ZEMXJPTRSA-N
SMILES string
N.C[C@@]1(CS(O)(=O)=O)[C@@H]2CC[C@@]1(C)C(=O)[C@H]2Br
assay
99%
form
powder
optical activity
[α]25/D +84.5°, c = 4 in H2O
mp
284 °C (dec.) (lit.)
Application
[(1R)-(endo,anti)]-(+)-3-Bromocamphor-8-sulfonic acid ammonium salt can be used as a chiral resolving reagent in the resolution of piperidine intermediate, which is used in the synthesis of ORL-1 antagonist named J-113397.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
A new synthesis of the ORL-1 antagonist 1-[(3R, 4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay
Smith ED, et al.
Bioorganic & Medicinal Chemistry, 16(2), 822-829 (2008)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持